» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

LONGBOARD PHARMACEUTICALS

WVB Number : USA000070986 Country : United States of America
SIC categorization : PHARMACEUTICAL PREPARATIONS (2834) ISIN : US54300N1037
FT categorization : HEALTH CARE (431)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company are a clinical-stage biopharmaceutical Company focused on developing novel, transformative medicines for neurological diseases.
Phone : 1 302-636-5401 Fax :
Chairman: : KEVIN ROBERT LIND Auditor : KPMG LLP
CEO/Managing Director : KEVIN ROBERT LIND

» Company Facts

Net Profit Margin (%) N/A  
Operating Margin (%) N/A  
Return on Assets (%) -51.21  
Return on Equity (%) 1,069.84  
Employees N/A  

» Company Financials

  Annual (2020)
Income Statement
('000 USD )
Sales/Total Revenue 0  
EBITDA -14,400  
EBIT -14,400  
Net Income -14,400  
Balance Sheet
( '000 USD)
Total Current Assets 55,362  
Total Assets 56,238  
Current Liabilities 3,135  
Total Liabilities & Debt 3,135  
Total Equity -2,692  
Cash & Flow
( '000 USD)
Net Income/Staring Line -14,400  
Cash from Operating -3,442  
Cash from Investing 0  
Cash from Financing 58,758  
Cash & Equivalent Yr End 55,316